Call for Abstracts
Abstract Submission Period
Tuesday, September 1, noon -
Tuesday, October 20, noon, 2026 (JST)
Information required for abstract submission
The non-Japanese first author from international institutions are not required to be a member of the society.
Authors who submit abstracts from institutions in Japan must be a member of the Japanese Society of Pathology (except for undergraduate students giving poster presentations). (Those who are applying for membership, please enter "99" in the "Membership Number" box.)
Inquiries regarding membership can be obtained at the Secretariat Office of the Japanese Society of Pathology. The details of the contact can be found at the bottom of this page.
Abstract submission
| Session | Deadline |
|---|---|
|
Tuesday, September 1, noon - Tuesday, October 20, noon, 2026 (JST) |
Presentation style
- Oral presentation
- Poster presentation
- No preference
- Poster presentation(Undergraduate students)
- Poster presentation(Trainees)
- Poster presentation (Postgraduate students, Residents)
Please note that we may ask you to present in a different presentation style from your preferred at the time of abstract acceptance.
Keywords *required
Keywords 1 *
| 1 | Human pathology (Morphological and immunohistochemical analyses, clinicopathological analysis) |
|---|---|
| 2 | Human pathology (Molecular pathological study such as genomic and epigenomic analyses) |
| 3 | Experimental Pathology (Analysis of disease models such as cultured cells and genetically engineering animals, molecular and cellular biology) |
Keywords 2-1 *
| 1 | Gene mutations and chromosomal abnormalities |
|---|---|
| 2 | Epigenetics |
| 3 | Gene expression |
| 4 | Signal transduction, cell proliferation and cell cycle |
| 5 | Cell death, cell damage and senescence |
| 6 | Neoplastic diseases |
| 7 | Carcinogenic factors |
| 8 | Characteristics of cancer cells |
| 9 | Tumor microenvironment |
| 10 | Invasion and metastasis |
| 11 | Tumor immunity |
| 12 | Inflammation and immunity |
| 13 | Inflammatory diseases |
| 14 | Autoimmune diseases |
| 15 | Transplant pathology |
| 16 | Infectious diseases |
| 17 | Circulatory failure and circulatory disorders |
| 18 | Metabolic and degenerative diseases |
| 19 | Congenital disorders and developmental abnormalities |
| 20 | Genomic abnormalities and hereditary diseases |
| 21 | Autopsy |
| 22 | Cytological diagnosis |
| 23 | Frozen section diagnosis |
| 24 | Differential diagnosis |
| 25 | Immunohistochemistry |
| 26 | Diagnostic markers and tumor markers |
| 27 | Disease classification |
| 28 | Therapeutic strategies and assessment of treatment efficacy |
| 29 | Development of novel therapies |
| 30 | Cell differentiation for regenerative medicine |
| 31 | Cellular biology and imaging |
| 32 | Image analysis and digital pathology |
| 33 | Epidemiology and statistics |
| 34 | Bioinformatics |
| 35 | Artificial Intelligence |
| 36 | Spatial transcriptomics and single-cell analysis |
| 37 | Metabolomics and integrated omics analysis |
| 38 | New technologies and experimental techniques |
| 39 | Quality control and medical safety |
| 40 | Education and human resource development |
| 41 | Task sharing and work-life balance |
| 42 | Others |
Keywords 2-2
Keywords 3 *
| 1 | Interdisciplinary pathology |
|---|---|
| 2 | Systemic diseases |
| 3 | Oral cavity・Head and neck・Salivary glands |
| 4 | Heart |
| 5 | Vessels |
| 6 | Respiratory tract |
| 7 | Mediastinum・Thymus |
| 8 | Serosal membranes・Mesothelium・Somatic cavity |
| 9 | Upper gastrointestinal tract |
| 10 | Lower gastrointestinal tract |
| 11 | Liver |
| 12 | Biliary system |
| 13 | Pancreas |
| 14 | Breast |
| 15 | Endocrine organs |
| 16 | Urinary system |
| 17 | Male reproductive organs |
| 18 | Female reproductive organs |
| 19 | Placenta and perinatal pathology |
| 20 | Pediatric pathology |
| 21 | Central nervous system |
| 22 | Peripheral nervous system |
| 23 | Bone and soft tissue・Locomotor organs |
| 24 | Blood・Bone marrow |
| 25 | Lymph nodes |
| 26 | Spleen |
| 27 | Skin |
| 28 | Sensory organs |
| 29 | Others |
Session Category
| 1 | Prefers presenting at cross-organ sessions. |
|---|---|
| 2 | Prefers presenting at organ-specific sessions. |
- Title
The title must be written in English.
Maximum number of letters: 100
*Titles with more than 100 letters cannot be registered. - Abstract (main text)
Abstract will be accepted in English only.
Maximum number of letters: 1040 - Co-author(s) / affiliation(s)
Co-author(s): up to 10 persons including the first author Affiliation(s): up to 10 institutions List of abbreviations used for affiliations: here - Selection of abstracts
Submitted abstracts will be peer-reviewed, and acceptance and presentation style will be decided by the program committee. Notifications of accepted abstract will be sent by e-mail to the authors.
Abstract Submission
Inquiries regarding Abstract Submission
Abstract Submission Secretariat
The 116th Annual Meeting of the Japanese Society of Pathology c/o Congrès Inc.
E-mail:jsp2027-abs@m.congre.co.jp